Kg-Free: an Acceptance, Mindfulness and Compassionate-based Intervention for Women Struggling With Their Weight (Kg-Free)

July 27, 2016 updated by: Lara Palmeira, University of Coimbra

Kg-Free: an Acceptance, Mindfulness and Compassionate-based Intervention for Women Struggling With Their Weight: A Randomized Controlled Trial

This study aims to test the efficacy and feasibility of an acceptance, mindfulness and compassionate-based intervention for women with overweight and obesity without binge-eating disorder (Kg-Free). Kg-Free intervention comprises 10 weekly group sessions plus 2 booster fortnightly sessions (31/2months) 2h30 hours each, run in small groups at Coimbra's University Hospital. The main goal of Kg-Free intervention is to reduce weight self-stigma and unhealthy eating behaviours and promote quality-of-life by targeting weight-related experiential avoidance and self-criticism patterns. The intervention focuses on fostering a greater awareness and ability to be in contact, tolerate and accept all internal experiences (even the unwanted ones, such as craving for food, fatigue, stigma and shame), rather than trying to avoid, control or change them. Additionally, the intervention intents for participant's to develop a compassionate attitude towards themselves, especially during challenging times in order to decrease shame and self-criticism.

Study Overview

Status

Completed

Detailed Description

This project aims to develop and test the efficacy of an integrated intervention (Kg-FREE), based on different and complementary approaches from the 3rd generation therapies (Acceptance and commitment therapies - ACT, Mindfulness and Compassion Focused Therapy) that have been showing promising results individually, but that were never tested simultaneously in intervention for people struggling with their eating and weight. Moreover, the intervention aims to act specifically on patients' self-criticism and experiential avoidance patterns in order to reduce weight-self-stigma and promote healthy behaviours and quality-of-life. Indeed, several studies have been suggesting the crucial role of these emotional regulation processes on behavioural modification. This study will investigate the impact of the changes in several psychological processes in different obesity dimensions, such as body mass and biochemical parameters associated with health risks, eating behaviours, stigma, health and quality of life.

The Kg-FREE intervention encloses 10 weekly group sessions (2, 5 hours/ each), highly experiential followed by two 2 booster fortnightly sessions. The intervention is divided into several modules, that are applied in a structured way: a) psycho education related to eating and physical exercise healthy habits; b) how our brain works and how does this relate to our eating and weight; c) Life values identifications to enhance intrinsic motivation; d) cognitive fusion and experiential avoidance as maladaptive strategies that underlie the psychological suffering, the negative affect (e.g. shame) and self-criticism; e) mindfulness exercises as a more adaptive strategy for emotional regulation; f) development of self-compassion as an antidote for shame and self-criticism, activating the soothing system and deactivating the threat system.

Kg-Free sessions were carried out by a clinical psychologist with previous training in contextual-behavioral therapies and one clinical psychology master student. The intervention protocol was built upon pre-existent ACT and mindfulness-based protocols for people with eating and weight issues (e.g., Forman et al., 2013; Kristeller & Wolever, 2011; Lillis et al., 2009; Tapper et al., 2009). Additionally, and because it has been recognized the importance of integrating compassion in behavioural interventions (e.g., Luoma & Platt, 2015), specially to deal with shame and self-criticism (Gilbert, 2010) a compassion component was added. This component aimed at training participants to develop a more accepting and kind relationship with themselves, particularly when things go wrong or when facing errors or failures.

All session followed the same basic structure, starting with 30 minutes of shared experience, followed by a five-minute mindfulness practice. Then the session content was delivered, followed by an eating mindfulness practice to train the ability to pay attention to food and eating physical sensations. Finally, the session content was briefly revised and practices for the week were established (e.g., mindfulness or compassion exercises). A participants' manual was provided, which included the targeted constructs, examples and exercise sheets. Audio files were given to the participants to ensure the practice of mindfulness and compassion exercises between sessions. Moreover, a Portuguese therapist manual was also assembled and is available upon request.

Previously to data collection, ethical approval was obtained from Clinical Trials Unit from Coimbra's University Hospital. Participants were adult women, aged between 18 and 55 years old, with overweight or obesity (BMI ≥ 25) without binge-eating, enrolled in nutritional treatment for weight loss in primary care units and Hospitals from Coimbra's district, Portugal. Participants were recruited directly at the medical care units in the day of their appointment. Participants were informed about the voluntary and confidential nature of the data. Also, a brief overview of the treatment program was presented and participants were required to sign the informed consent. In order to assure confidentiality a numerical unique code was assigned to each participant.

After eligibility assessment, participants that meet inclusion criteria were randomly assigned into one of the two study conditions - experimental group that will receive the Kg-Free intervention and a control group that will maintain Treatment as usual (which consisted in dietary and physical activity support), using a using a computer-based random allocation. The study followed the principle of treatment received.

The study comprised four different assessment moments (M0, M1, M2 e M3), namely before intervention (M0), at the end of the intervention (M1) and two follow-up moments at three (M2) and six months (M3) after the intervention. In all assessments data regarding participants' biochemical (lipid profile) and body mass parameters, eating behaviours, health, stigma and quality of life as well as psychological processes was collected. Regarding biochemical data, the blood samples were collected and analysed by the clinical analysis laboratory from the Pharmacy department. Confidentiality was assured hence only the research code for each participant was provided to the laboratory. All participants were weighted with their street clothes (without shoes) using the same Body Composition Analyzer (Tanita TBF-300) accurate to 0.1kg. Waist circumference was measured using a tape measure at the umbilicus. The remaining data collection was carried out by clinical psychologists from the research team (blinded to participant's treatment condition).

Statistical analysis All data analyses were performed using Statistical Package for the Social Sciences (SPSS, V.20) and alpha level was set at .05. Independent sample t tests were used in order to compare intervention and control groups at baseline. Power analysis for ANCOVA was calculated at priori. Using a significance level of p<.05 and a power of 80%, a sample size of 31 per group (N = 62) was needed to detect a standardized effect size of f = 0.40.

To test between-group differences at post-treatment ANCOVA with baseline as covariate and condition as a fixed factor were performed. Paired samples t-tests were performed to explore within-group differences from pre to post test, for each group separately. All effect sizes were calculated using Cohen's d.

In a second study, Repeated Measures ANOVA was performed to test differences between pre-treatment, post- treatment and 3month follow-up assessments for all participant's that completed Kg-Free intervention (N = 53). Whenever sphericity assumption was violated, the Greenhouse-Geisser correction was used to produce a valid F-ratio. Post-Hoc analyses using Bonferroni adjustment for multiple comparisons was used to explore pairwise differences (pre-to-post treatment; pre-to-3 months and post-to-3 months). Effect sizes were calculated using partial eta square (ƞ2). Finally, to explore the psychological processes that underlie the changes in health and weight and eating-related outcomes after the Kg-Free intervention MEMORE macro (Mediation and Moderation analysis for Repeated measures designs) was used. MEMORE allows for the estimation of total, direct, and indirect effects of independent variable (X) on dependent variable (Y) through one or more mediators (M) simultaneously two-occasion within-subjects design.

Study Type

Interventional

Enrollment (Actual)

73

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women with overweight or obesity (BMI above 25);
  • Enrolled in nutritional treatment for weight loss in primary care units and Hospitals from Coimbra

Exclusion Criteria:

  • Binge Eating Disorder assessed through Eating Disorders Examination Interview;
  • Severe psychiatric problems (severe depressive episode, substance abuse, Bipolar disorder and Borderline Personality Disorder) assessed through Structured Clinical Interview for DSM Disorders (SCDI-I and SCID-II);
  • medical conditions that affect weight;
  • medication that can cause significant weight or appetite changes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Kg-Free
Kg-free is a manualized acceptance, mindfulness & compassionate-based group intervention for women struggling with their weight. It comprises 10 weekly group sessions plus 2 booster fortnightly sessions (31/2months) 2h30 hours each, run in small groups (ranging from 10 to 12 participants).
Cognitive-behavioral intervention based on promoting acceptance, mindfulness and self-compassion abilities
Standard nutritional treatment that involves dietary and physical activity support provided by the medical units Standard
Other: Treatment as Usual (TAU)
nutritional treatment for weight loss in primary care units and Hospitals from Coimbra's district that includes dietary and physical activity support
Standard nutritional treatment that involves dietary and physical activity support provided by the medical units Standard

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in weight self-stigma
Time Frame: 9 months (from Baseline to 6-months follow-up)
Assessed by Weight self-stigma questionnaire (WSSQ)
9 months (from Baseline to 6-months follow-up)
Changes in eating behaviours
Time Frame: 9 months (from Baseline to 6-months follow-up)
Assessed by the Three Factor Eating Questionnaire (TFEQ-R21)
9 months (from Baseline to 6-months follow-up)
Changes in obesity-related quality-of-life
Time Frame: 9 months (from Baseline to 6-months follow-up)
Assessed by Obesity Related Well-Being Questionnaire (ORWELL)
9 months (from Baseline to 6-months follow-up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in BMI
Time Frame: 9 months (from Baseline to 6-months follow-up)
Measured with a Body Composition Analyzer (Tanita TBF-300)
9 months (from Baseline to 6-months follow-up)
Changes in Lipidic Profile (Total, HDL, LDL Cholesterol and Triglycerides)
Time Frame: 9 months (from Baseline to 6-months follow-up)
Data collected and analysed by the clinical analysis laboratory from the Pharmacy department
9 months (from Baseline to 6-months follow-up)
Changes in Physical exercise frequency
Time Frame: 9 months (from Baseline to 6-months follow-up)
Interview
9 months (from Baseline to 6-months follow-up)
Changes in psychopathological symptoms
Time Frame: 9 months (from Baseline to 6-months follow-up)
Assessed by the General Health Questionnaire (GHQ)
9 months (from Baseline to 6-months follow-up)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Weight-related experiential avoidance
Time Frame: 9 months (from Baseline to 6-months follow-up)
Assessed by Acceptance and Action Questionnaire for Weight-Related Difficulties-Revised (AAQW-R)
9 months (from Baseline to 6-months follow-up)
Changes in Self-criticism
Time Frame: 9 months (from Baseline to 6-months follow-up)
Assessed by Forms of Self-Criticising/Attacking & Self-Reassuring Scale (FSCRS)
9 months (from Baseline to 6-months follow-up)
Changes in Self-compassion
Time Frame: 9 months (from Baseline to 6-months follow-up)
Assessed by Self-Compassion Scale (SCS)
9 months (from Baseline to 6-months follow-up)
Changes in Mindfulness
Time Frame: 9 months (from Baseline to 6-months follow-up)
Assessed by Five Facet Mindfulness Questionnaire (FFMQ-15)
9 months (from Baseline to 6-months follow-up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: José A. Pinto-Gouveia, PhD, CINEICC's Coordinator, University of Coimbra

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

June 1, 2016

Study Registration Dates

First Submitted

July 22, 2016

First Submitted That Met QC Criteria

July 27, 2016

First Posted (Estimate)

August 1, 2016

Study Record Updates

Last Update Posted (Estimate)

August 1, 2016

Last Update Submitted That Met QC Criteria

July 27, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CINEICC-01-LP
  • SFRH/BD/84452/2012 (Other Grant/Funding Number: FCT (Portuguese Foundation for Science and Technology))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Kg-Free

3
Subscribe